Alkermes
overview of clinical development program | Alkermes
Company
Deck Type
Sector
Industry
Deck date
June 2021
Slide
7 of 31
Related slides by other companies
Genelux
Investor Presentation
July 2023
demonstrates and immune activation patient samples a | Genelux
Genelux
Investor Presentation
February 2024
demonstrates and immune activation patient samples a | Genelux
Apexigen
Investor Presentation
September 2022
patient case study significant response to combination lasting years | Apexigen
Kymera
Investor Presentation
December 2023
partial response and stable disease observed across multiple tumor types during dose of | Kymera
Other recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights